	Evolving Treatment Patterns and Clinical Outcomes in Children with Newly Diagnosed Crohn's Disease and Ulcerative Colitis in the United States, 2007-2023. Am J Gastroenterol Gonzalez MM, Ahuja D, Qi Y, Xu R, Jairath V, Goodwin SW, Olen O, Faubion WA, Kappelman MD, Singh S. PMID: 42841617 [PubMed - as supplied by publisher]
	Multi-omics and machine learning identify neutrophil annexin A3 as a therapeutic target of ginsenoside Rb1 for comorbidity of ischaemic stroke and ulcerative colitis. Br J Pharmacol Zhou J, Li P, Yu E, Chen J, Zhou M, Li Y, Hu J, Guo S, Hu H, Yuan Y, Zhao Y. PMID: 42841525 [PubMed - as supplied by publisher]
	Engineering Nanomaterial Platform for Inflammatory Bowel Disease: Three-Dimensional Integration of Delivery Mechanism, Therapeutic Drug Delivery and Intelligent Material Design. Int J Nanomedicine Qian J, Shen S, Chen S, Zhang H, Liu L, Zhou D, Zhang X. PMID: 42841048 [PubMed - indexed for MEDLINE]
	Real-world effectiveness and predictors of need for extended induction of mirikizumab therapy in ulcerative colitis. J Can Assoc Gastroenterol McShane C, Kalisky I, Moore JS, Milgrom R, Stempak J, Olivera PA, Nguyen G, Croitoru K, Huang VW, Targownik LE, Weizman AV, Steinhart AH, Gallinger Z, Lee SH, Rosenfeld G, Silverberg MS. PMID: 42840560 [PubMed]
	Efficacy of Fermented Brown Rice by Aspergillus oryzae (FBRA) in Ulcerative Colitis: A Double-Blind Randomized Trial. JGH Open Ishikawa H, Onishi Y, Kataoka K, Murakami Y, Mutoh M, Kobayashi H. PMID: 42840273 [PubMed]
	Accelerometer-measured physical activity and risk of incident ulcerative colitis: a population-based prospective study. Front Public Health Li Z, Ke H, Feng H, Lin Q, Chen Y. PMID: 42840121 [PubMed - indexed for MEDLINE]
	Biologic therapy for Crohn's disease (2015-2025): a bibliometric analysis of global research trends and current status. Front Pharmacol Zhou P, Pan H, Wei M, Zhou Y, Qu H, Wang J, He Y. PMID: 42839945 [PubMed]
	Beyond Crohn's disease: ileal Kaposi sarcoma in a transplant recipient presenting with subocclusive symptoms. A concomitant diagnosis of Crohn's disease and ileal Kaposi sarcoma. Minerva Gastroenterol (Torino) Pezzella C, Locorotondo L, Chiera E, DI Vincenzo F, Del Gaudio A, Capobianco I, Laterza L, Lopetuso LR, Cammarota G, Gasbarrini A, Scaldaferri F. PMID: 42839839 [PubMed - as supplied by publisher]
	Disease characteristics, outcomes, and poor prognostic factors of perianal fistula in Korean patients with Crohn's disease: a multicenter, retrospective observational study. Intest Res Yoon H, Kang SB, Koh SJ, Lee CK, Kim D, Kim ES, Hong SN, Kim DH, Lee JW, Park SJ, Choi CH, Jang BI, Song EM, Park SK, Kim Y, Choi JM, Jung SY, Lee Y, Park SH. PMID: 42838526 [PubMed - as supplied by publisher]
	Intestinal ultrasound in the assessment of complicated Crohn's disease: a comprehensive review. Intest Res Kim MK, Hwang SW. PMID: 42838522 [PubMed - as supplied by publisher]
	EFFICACY AND SAFETY OF ADVANCED THERAPIES AS INDUCTION THERAPY FOR ULCERATIVE COLITIS: AN UPDATED SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Clin Gastroenterol Hepatol Olivera PA, Lasa JS, Singh S, Jairath V, Fumery M, Sands BE, Danese S, Peyrin-Biroulet L. PMID: 42838315 [PubMed - as supplied by publisher]
	Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies. Immun Inflamm Dis Lai Q, Zhang QY, Yang WP, Luo CY. PMID: 42836569 [PubMed - indexed for MEDLINE]
	Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study. J Crohns Colitis Shehab M, Azzam N, Al-Hindawi A, Alrashed F, Al-Bawardy B, Abid S, Bashandi AA, AlShihri RM, Mukhtar M, Saadah O, Alharbi O, Al-Darmaki A, Al Harthi S, Al-Ejji K, Ayash A, Al Sahli A, Khamees N, Salem OE, Mohamed EA, Maher M, Daba G, Helal AA, Abdulhakim Alnassar M, Alfadhli A, Quraishi MN, Goodwin SW, Yuan Y, Mosli M, Jairath V. PMID: 42832339 [PubMed - indexed for MEDLINE]
	Post-Operative Ketorolac in Children After Crohn's Ileocecectomy. Pediatr Surg Int Kennedy K, Hwang R, Krumbhaar C, Zhao Y, Penney C, Baxelbaum K, Mitchel E, Grossman A, Mattei P. PMID: 42832108 [PubMed - indexed for MEDLINE]
	Impact of Vedolizumab on Bowel Urgency in Ulcerative Colitis: Post Hoc Analysis of the GEMINI 1, VISIBLE 1, and VARSITY Trials. Gastro Hep Adv Collins AE, Gift T, Kim E, Robinson I. PMID: 42831144 [PubMed]
	ACEBROPHYLLINE REPROGRAMS INFLAMMATORY AND REDOX SIGNALLING IN EXPERIMENTAL ULCERATIVE COLITIS: A DOSE-DEPENDENT STUDY. Georgian Med News Salman O, Al-Zubaidy A. PMID: 42830053 [PubMed - indexed for MEDLINE]
	Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease. Drug Des Devel Ther Zhang Y, Wang N, Zheng W, Liu R, Li L, Zhao X, Zheng X, Han X. PMID: 42829521 [PubMed - indexed for MEDLINE]
	Spatial multi-omics-guided drug development in inflammatory bowel disease: from mucosal immune niches to precision therapy. Front Immunol Wang H, Zhao X, Yang J. PMID: 42828167 [PubMed - indexed for MEDLINE]
	Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis. Front Gastroenterol (Lausanne) Alabdallat MY, Al Ta'ani O, Bakain T, Al-Dwairy A, Ghannam M, Atasi A, Mashal F, Moghib K, Bakheet N, Jagroo JG, Hehr R, Salem A, Cheung D. PMID: 42827438 [PubMed]
	Neutrophil extracellular traps as a potential therapeutic target in inflammatory bowel disease: a systematic review and meta-analysis. Front Immunol Wu YJ, Huang Y, Fang H, Gu BY, Ge HC, Xu RY, Qian JM, Qin DP. PMID: 42824291 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 59024

Page 1 of 2952



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy